ZHX2 Inhibitors
Chemical inhibitors of ZHX2 function by impeding various signaling pathways and cellular processes that are essential for the protein's role as a transcriptional repressor. GW5074, as a RAF kinase inhibitor, disrupts the RAS/RAF/MEK/ERK signaling pathway, which is crucial for the transcriptional repression functions of ZHX2. Similarly, PD98059 and U0126 are both MEK inhibitors that prevent the activation of ERK, another key player in the signaling cascade that ZHX2 is part of. By blocking ERK activation, these inhibitors directly obstruct the pathway that enables ZHX2 to exert its influence on gene expression. Whereas SP600125, a JNK inhibitor, can reduce the transcriptional repression activity of ZHX2 by altering the JNK signaling pathway. This pathway can modulate the activity of transcription factors that ZHX2 may interact with, thereby affecting its function.
Additionally, LY294002 and Wortmannin, both PI3K inhibitors, lead to the inhibition of AKT phosphorylation, a necessary step for the transcriptional repression activity of ZHX2. SB203580 targets the p38 MAPK signaling pathway, which plays a role in the transcriptional repression activities of ZHX2, thus its inhibition can lead to a reduction in ZHX2's functional capabilities. The compound Rapamycin inhibits mTOR, a kinase involved in regulating cell growth and proliferation, thereby indirectly affecting ZHX2's operational environment. Trichostatin A, an HDAC inhibitor, potentially hinders ZHX2's ability to interact with chromatin due to changes in the acetylation status of histones and non-histone proteins. Alsterpaullone, a cyclin-dependent kinase inhibitor, can impede cell cycle progression and subsequently the role of ZHX2 which is linked to transcriptional regulation associated with cell cycle. Thapsigargin, by increasing cytosolic calcium levels through SERCA pump inhibition, can affect signaling pathways and processes involving ZHX2. Lastly, Staurosporine, a broad-spectrum kinase inhibitor, can inhibit a variety of signaling pathways that regulate transcription factors and co-repressors interacting with ZHX2, thus impeding its transcriptional repressor function.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
GW5074 is a RAF kinase inhibitor that can inhibit ZHX2 by disrupting the RAS/RAF/MEK/ERK signaling pathway, which ZHX2 has been implicated in through its interaction with the NF-kB complex, leading to the inhibition of its transcriptional repressor functions. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that prevents the activation of ERK, thereby inhibiting the downstream signaling pathways in which ZHX2 is involved, specifically hindering its ability to modulate DNA-binding and repress transcriptional activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor which, by inhibiting the JNK signaling pathway, can reduce the transcriptional repression activity of ZHX2, given that JNK pathway can modulate the activity of transcription factors that ZHX2 may interact with. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can lead to the inhibition of AKT phosphorylation, a process necessary for the full transcriptional repression activity of ZHX2, thus impeding its function in the cell. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of both MEK1 and MEK2, which could inhibit ERK activity and thereby inhibit ZHX2's ability to function as a transcriptional repressor, as ERK activity is related to the regulation of transcription factors. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that can inhibit the p38 signaling pathway, a pathway in which ZHX2 is involved through its transcriptional repression activities, thereby leading to the functional inhibition of ZHX2. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor like LY294002, which can inhibit the AKT pathway, necessary for the full activity of ZHX2 as a transcriptional repressor, thus impeding its function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in cell growth and proliferation pathways that can indirectly involve ZHX2 function by altering the cellular environment in which ZHX2 operates, leading to its functional inhibition. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an HDAC inhibitor, which can alter the acetylation status of histones and non-histone proteins like ZHX2, potentially hindering its ability to interact with chromatin and inhibit its function as a transcriptional repressor. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Alsterpaullone is a cyclin-dependent kinase inhibitor, which can inhibit the cell cycle progression and thus indirectly inhibit ZHX2, which is implicated in transcriptional regulation linked to cell cycle processes. | ||||||